5-氨基乙酰丙酸诱导的荧光在原发性中枢神经系统淋巴瘤中的应用
这项回顾性研究纳入两家大学医院近4年内因占位效应或疑似脑胶质瘤而接受手术切除的11例原发性中枢神经系统淋巴瘤患者,术前给予5-氨基乙酰丙酸行荧光引导切除;术后病理均为恶性B细胞淋巴瘤,形态符合弥漫大B细胞淋巴瘤,11例中8例显示5-ALA诱导的清晰荧光,术后接受联合化疗。
要点
- 11例原发性中枢神经系统淋巴瘤患者术前接受5-ALA荧光引导切除,8例显示清晰荧光。
- 术后病理均示恶性B细胞淋巴瘤,形态符合弥漫大B细胞淋巴瘤。
- 作者认为若在临床研究中对特定患者重新考虑手术,5-ALA可用于PCNSL手术入路。
核心结论
- 作者认为,若在临床研究中对特定患者重新考虑手术,5-ALA用于原发性中枢神经系统淋巴瘤应被纳入手术入路,5-ALA联合光动力疗法也可能值得研究。
研究设计与样本
- 回顾性研究,纳入两家大学医院近4年内因即将发生的占位效应或疑似脑胶质瘤而接受手术切除的11例原发性中枢神经系统淋巴瘤患者的临床、磁共振成像、病理和手术资料,术前给予5-ALA行荧光引导切除。
主要发现
- 11例受试者年龄范围为59至81岁。
- 术后病理检查显示恶性B细胞淋巴瘤,形态符合弥漫大B细胞淋巴瘤。
- 11例原发性中枢神经系统淋巴瘤患者中8例显示5-ALA诱导的清晰荧光。
- 手术切除后患者接受联合化疗方案治疗。
临床怎么用
- 作者认为,若在临床研究中对特定患者重新考虑手术,5-ALA用于原发性中枢神经系统淋巴瘤应被纳入手术入路。
- 作者提出,5-ALA联合光动力疗法也可能值得研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Diagnosis of primary central nervous system lymphoma (PCNSL) is usually confirmed by brain biopsy and subsequent neuropathologic workup. 5-Aminolevulinic acid (5-ALA)-induced fluorescence has been established for diagnostic and therapeutic purposes in glioma treatment during the last few years and is discussed for use in other cranial tumors. Its role in diagnosis and treatment of PCNSL is still elusive. METHODS: This retrospective study includes clinical, magnetic resonance imaging, pathologic and surgical data of selected 11 patients with PCNSL at two university hospitals within the last 4 years undergoing surgical treatment for resection because of imminent mass effect or suspected cerebral glioma. Patients received 5-ALA for fluorescence-guided resection preoperatively. RESULTS: The 11 subjects age ranged from 59 to 81 years. Postsurgical pathologic workup revealed malignant B cell lymphoma with morphologic features of diffuse large B cell lymphoma. Eight of these 11 patients with PCNSL showed a clear fluorescence induced by 5-ALA. After surgical resection, patients were treated with combination chemotherapy regimens. CONCLUSION: In patients with glioma, the use of 5-ALA is known to be associated with increased extent of resection and survival benefit. Our data and retrospective analysis of a larger patient cohort suggest that the use of 5-ALA in PCNSL should be included in a surgical approach, if this is reconsidered for select patients within a clinical study. In addition, even photodynamic therapy in combination with 5-ALA might be studied.
引用
- Evers G, Kamp M, Warneke N, et al. 5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma. World Neurosurg. 2016. PMID: 27838426. doi:10.1016/j.wneu.2016.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。